NCT06896422
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- the First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
Clinical trial condition
PD1 Antibody
Explore clinical trials studying PD1 Antibody. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
PD1 Antibody trial results
Active, Not Recruiting
Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC Downstaging
NCT07581769
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
- Locations
-
- The First Affiiated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
- Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
Active, Not Recruiting
Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
NCT04669496
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
- Locations
-
- Zhongshan hospital Shanghai, Shanghai Municipality, China